Haisheng Yu

Hubei Key Laboratory Of Tumor Biological Behaviors
China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.

Author Correction: ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.

Journal: Nature communications
Published: June 20, 2025

Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy.

Destruction of VISTA by TRIM25 ablation in T cells potentiates cancer immunotherapy.

Journal: Cell research
Published: March 24, 2025

Energy status orchestrates YTHDF1 phase separation and tumorigenesis.

Energy status orchestrates YTHDF1 phase separation and tumorigenesis.

Journal: Cell reports
Published: February 14, 2025

ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion.

ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion.

Journal: Cancer research
Published: January 16, 2025

Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy.

Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 08, 2024

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy.

USP8-governed GPX4 homeostasis orchestrates ferroptosis and cancer immunotherapy.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2024

USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity.

USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity.

Journal: Nature communications
Published: April 01, 2024

UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity.

UFL1 ablation in T cells suppresses PD-1 UFMylation to enhance anti-tumor immunity.

Journal: Molecular cell
Published: May 30, 2023

Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.

Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy.

Journal: Cell chemical biology
Published: October 11, 2022

ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.

ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy.

Journal: Nature communications
Published: September 28, 2022

Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition.

Hepatitis B virus rigs the cellular metabolome to avoid innate immune recognition.

Journal: Nature communications
Published: December 14, 2019

O-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5.

O-GlcNAc transferase promotes influenza A virus-induced cytokine storm by targeting interferon regulatory factor-5.

Journal: Science advances
Published: October 02, 2019
Showing 1-12 of 18

Last Updated: 09/26/2026